EUVIMEDEUVIMED entdecken
Crossref

Trends in Commercial Laboratory Testing and Positivity for Bordetella Species in the United States, 2019 Through 2023

Cheryl J Isenhour, Lucia Pawloski iD, Susan Hariri iD, Tami H Skoff

The Journal of Infectious Diseases · 15.10.2025 · 232 (4) · e601-e608

DOI: 10.1093/infdis/jiaf141 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infectious Diseases, online erschienen am 21.03.2025. Verfasst von Cheryl J Isenhour und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georg…. Hauptthemen laut MEDLINE: Bordetella pertussis, Bordetella Infections, Bordetella parapertussis, Whooping Cough. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Diagnostic methods for detecting infections caused by Bordetella species include culture, polymerase chain reaction (PCR), and serology. As the epidemiology of pertussis continues to evolve in the United States, we aimed to assess recent trends in provider testing practices and positivity for both Bordetella pertussis and Bordetella parapertussis.

Methods

Using deidentified data from a large US commercial laboratory, we identified Bordetella tests from 2019 through 2023. We described monthly trends in number of tests ordered by test type for culture, PCR (both nonpanel B. pertussis and B. parapertussis tests and those included as part of a respiratory panel), and serology, as well as percent positivity for serology and PCR. We also examined orders and positivity by patient age group and geographic region of the ordering provider.

Results

Among 527 206 tests, we identified 316 428 (60.1%) PCR tests, 204 480 (38.8%) serologic tests, and 5840 (1.1%) cultures. While most PCR tests were ordered as part of a respiratory panel (83.5%), only 215 (0.08%) were positive for B. pertussis. Nonpanel PCR positivity for B. pertussis was substantially higher but variable over the study period, ranging from 3% to 16%. We also observed a notable increase in B. parapertussis positivity on nonpanel PCR tests in the first half of 2023.

Conclusions

Both PCR and serology remain preferred diagnostic methods for providers. Despite their increasing popularity, B. pertussis positivity remained low for respiratory panels. Data from commercial laboratories can provide crucial insights into pertussis diagnostic trends over time.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bordetella pertussisBordetella InfectionsBordetella parapertussisWhooping CoughBordetellaHumansUnited StatesAdultChild, PreschoolInfantMiddle AgedAdolescentChildYoung AdultPolymerase Chain ReactionMaleFemaleAgedSerologic Tests

Stichwörter der Autor:innen

Bordetella parapertussisBordetella pertussisBordetella testingcommercial laboratory testingwhooping cough

Autor:innen und Institutionen

  • Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

ORCID-Profile: Lucia Pawloski, Susan Hariri

Zitieren

APA

Isenhour, C. J., Pawloski, L., Hariri, S., & Skoff, T. H. (2025). Trends in Commercial Laboratory Testing and Positivity for Bordetella Species in the United States, 2019 Through 2023. The Journal of Infectious Diseases, 232(4), e601-e608. https://doi.org/10.1093/infdis/jiaf141

Vancouver

Isenhour CJ, Pawloski L, Hariri S, Skoff TH. Trends in Commercial Laboratory Testing and Positivity for Bordetella Species in the United States, 2019 Through 2023. The Journal of Infectious Diseases. 2025;232(4):e601-e608. doi:10.1093/infdis/jiaf141

BibTeX
@article{Isenhour2025,
  author = {Isenhour, Cheryl J and Pawloski, Lucia and Hariri, Susan and Skoff, Tami H},
  title = {Trends in Commercial Laboratory Testing and Positivity for Bordetella Species in the United States, 2019 Through 2023},
  journal = {The Journal of Infectious Diseases},
  year = {2025},
  volume = {232},
  number = {4},
  pages = {e601--e608},
  doi = {10.1093/infdis/jiaf141}
}
Kostenlos starten →